Healthy Lifestyle Before and During Pregnancy to Prevent Childhood Obesity - the PRE-STORK-trial
1 other identifier
interventional
360
1 country
1
Brief Summary
Introduction: The prevalence of childhood overweight and obesity has risen from just 4% in 1975 to more than 18% in 2016. Little is known about adiposity of the infant, but it positively associates to the mother's BMI. Globally, the prevalence of overweight has tripled since 1975 and is now affecting one of three Danish women at the time of pregnancy. However, despite increasing awareness of obesity and accumulating evidence of its health consequences limited effect of intervention in childhood obesity exists. Maternal obesity before conception, an excessive increase in body weight during pregnancy and physical inactivity are some of the risk factors suspected of infant adiposity. Lifestyle interventions during pregnancy have shown limited or no effect in the offspring. Therefore, renewed effort to improve the prevention of childhood obesity is warranted. Methods and analysis: This is a randomized, parallel group, tailored, multifactorial lifestyle intervention trial in women (age 18 to 38 years) with overweight or obesity (BMI 27 to 42 kg/m2) seeking pregnancy. The women are randomized 1:1 to either the lifestyle or standard of care group. The lifestyle intervention is initiated prior to pregnancy. The lifestyle intervention is set off with a low-calorie diet for 8 weeks and throughout the intervention period (prior to and during pregnancy) participants follow an intervention containing exercise according to the World Health Organization guidelines, healthy diet and mentorship to maintain healthy weight before and during pregnancy.The primary outcome is the difference in neonatal adiposity measured at birth. Finally, a child and family cohort will be established to follow the children throughout childhood for healthy weight development. The study will provide evidence of effects from pre-conception-initiated intervention and have the potential to improve health and quality of life for children. Ethics and dissemination: The trial has been approved by the ethical committee of the Capital Region of Denmark (H-22011403) The trial will be conducted in agreement with the Declaration of Helsinki and monitored to follow the guidelines for good clinical practice. Results will be submitted for publication in international peer-reviewed scientific journals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2022
CompletedFirst Posted
Study publicly available on registry
October 13, 2022
CompletedStudy Start
First participant enrolled
October 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2029
April 16, 2026
February 1, 2026
6.7 years
October 5, 2022
April 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neonatal adiposity
Total fat mass (in gram) assessed by air displacement plethysmography (PEA POD).
Assessed at birth or up to 72 hours postpartum.
Secondary Outcomes (70)
Foetal and infant body weight
Assessed during pregnancy (week 18-21, 24-28 and 34), at birth and 3 months after birth.
Foetal and infant abdominal circumference
Assessed during pregnancy (week 18-21, 24-28 and 34), at birth and 3 months after birth.
Foetal and infant femur length
Assessed during pregnancy (week 18-21, 24-28 and 34), at birth and 3 months after birth.
Foetal and infant head circumference
Assessed during pregnancy (week 18-21, 24-28 and 34), at birth and 3 months after birth.
Placenta function (during pregnancy)
Assessed during pregnancy (week 34).
- +65 more secondary outcomes
Other Outcomes (54)
Fertility treatment (women)
Assessed up to 2 years.
Body weight (partner)
Assessed prior to pregnancy of the woman (baseline and 6 months), during pregnancy (week 11-14) and 3 months after birth.
Height (partner)
Assessed prior to pregnancy of the woman (baseline)
- +51 more other outcomes
Study Arms (2)
Lifestyle group
EXPERIMENTALA tailored multifactorial lifestyle intervention consisting of diet, exercise and mentorship in women with overweight or obesity to obtain a healthy lifestyle before and during pregnancy.
Standard of care group
NO INTERVENTIONThe standard of care group will receive no active intervention but are encouraged to seek any possible guidance from the general practitioner for management of pre-pregnancy obesity according to current guidelines.
Interventions
An initial 8 weeks of low-calorie diet including meal replacements (total of 800 kcal/day) will be initiated with the objective to lose at least 10% of initial body weight. From week 8 until week 12, an individual food-reintroduction plan will take place with partial meal product substitution. At week 12 and until pregnancy dieticians will ensure sustained compliance with diet aligned with the general recommendations for women seeking pregnancy (low-fat diet, rich in protein and carbohydrates and in some individuals slightly carbohydrate-reduced diet (prediabetes or family disposition to diabetes) with focus on carbohydrate quality (more fiber and whole grain). Consultations with a dietician for mapping diet and eating patterns and regular follow-up with a dietitian to maintain diet changes and modify diets if needed.
After an initial 8-week ramp-up phase (during the initial low-calorie diet), the women will be encouraged to attend supervised exercise sessions on the study location (combination of vigorous-intensity, interval-based indoor cycling, and circuit training) twice weekly and to perform additional moderate-to vigorous-intensity exercise to obtain at least 150 min per week of moderate-intensity or 75 min per week of vigorous-intensity physical activity or a combination. The plan will include individual exercise and/or group exercise. Exercise watches with heart-rate monitors will be worn at each exercise session to determine whether the requirement regarding weekly time spent at moderate or vigorous intensity will be met. Regular follow-up with the women to maintain exercise changes and modify the exercise plan if needed.
Women are offered an individualized plan to successfully fulfil the multifactorial lifestyle intervention and the women will be offered both individual and/or group sessions with a mentor. After 8 weeks of the intervention, the women will be invited to another meeting where the choice of mentor will be evaluated, and the women will be offered to join a "pre-parents-group". Group sessions will include conversational sessions, cooking classes and exercise classes with focus on changing lifestyle and maintaining a healthy lifestyle change. At the time of pregnancy groups will be reconsidered and the women will be offered participation in "pregnancy-groups".
Eligibility Criteria
You may qualify if:
- Having overweight or obesity (BMI 25-44 kg/m2)
- Age 18-34 years (no previous pregnancy) or 18-40 years (previous pregnant \>16 weeks)
- Planning a pregnancy within the next year
- Willingness to lose at least 10% of initial body weight before pregnancy and be physically able to adhere to WHO physical activity recommendations when entering the study
- Willing to postpone pregnancy until at least 6 months after randomization
- Planning antenatal care and delivery at either Herlev Hospital or Odense University Hospital
- Danish or English speaking
You may not qualify if:
- Diabetes (fasting plasma glucose (FPG) \>7 mmol/l and HbA1c ≥48 mmol/mol)
- Previous gestational diabetes mellitus (GDM) treated with insulin during pregnancy
- Polycystic ovary syndrome (PCOS) treated with metformin
- Treatment with medication which significantly affect glucose metabolism, appetite, or energy balance
- The use of medications that cause clinically significant weight gain or loss
- Habitual abortion (more than 3 abortions in a row)
- Known infertility (defined as fertility treatment and/or no obtained conception with the same partner after trying \>12 months)
- Previous bariatric surgery
- Significant psychiatric disorders
- Uncontrolled/severe medical issues including cardiovascular, pulmonary, rheumatologic, hematologic, oncologic, infectious, or endocrine disease
- Regular exercise training at high intensity (e.g., spinning) \>3 hours per week
- Known eating disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Steno Diabetes Center Copenhagenlead
- University of Copenhagencollaborator
Study Sites (1)
Steno Diabetes Center Copenhagen
Herlev, 2730, Denmark
Related Publications (1)
Kornerup N, Danielsen JH, Sahl RE, Pico ML, Johansen MY, Knop FK, Bonnelykke K, Bergholt T, Kelstrup L, Foghsgaard S, Ghauri N, Gronlund E, Lund L, Vinter CA, Lyng Forman J, Barres R, Kragelund Nielsen K, Andersen A, Torekov SS, Groth Grunnet L, Vilsboll T. Healthy lifestyle before and during pregnancy to prevent childhood obesity: study protocol for a parallel group randomised trial - the PRE-STORK trial. BMJ Open. 2025 Jan 25;15(1):e087895. doi: 10.1136/bmjopen-2024-087895.
PMID: 39863406DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tina Vilsbøll, Professor
Steno Diabetes Center Copenhagen
- PRINCIPAL INVESTIGATOR
Louise G. Grunnet, PhD
Steno Diabetes Center Copenhagen
- PRINCIPAL INVESTIGATOR
Signe Torekov, Professor
University of Copenhagen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Statistical analysis of the primary outcome will be blinded to the assessors.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2022
First Posted
October 13, 2022
Study Start
October 26, 2022
Primary Completion (Estimated)
July 1, 2029
Study Completion (Estimated)
July 1, 2029
Last Updated
April 16, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
The data will be available upon reasonable request. The dataset contains protected health information and will not be available online. Study results will be available by contacting the corresponding author. A proposal must be submitted to the PRE-STORK steering committee. If approved, data will be available.